Log In
Print
BCIQ
Print
Print this Print this
 

Xaluprine, mercaptopurine

  Manage Alerts
Collapse Summary General Information
Company Nova Laboratories Ltd.
DescriptionOral formulation of mercaptopurine, a DNA synthesis inhibitor
Molecular Target
Mechanism of ActionDNA synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationAcute lymphoblastic leukemia (ALL)
Indication DetailsTreat acute lymphoblastic leukemia (ALL)
Regulatory Designation EU - Orphan Drug (Treat acute lymphoblastic leukemia (ALL))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today